NYSE: BTI$ 40.995(-0.012)
Recently you have probably started to hear a lot about Tobacco Harm Reduction or “THR” from us and moving forward, you’re going to hear a lot more. THR is an approach to improve public health outcomes by focusing on what we believe is one of the most important movements for America’s health agenda – reducing … Continued
Recently, the National Youth Tobacco Survey (NYTS) results were released, which showed the continued decline in youth e-cigarette (Vapor Products) use, which is now at the lowest level in a decade, and down 71% since its peak in 2019. At Reynolds American, underage access prevention (UAP) is more than a policy; it is … Continued
This week, Reynolds American Inc. (Reynolds), published an opinion piece in the Washington Post, penned by Wade Huckabee, SVP of Strategy & Transformation, on transitioning adult smokers away from combustible cigarettes to potentially less risky products to improve public health in the US. Reynolds supports adult nicotine consumer choice, sensible regulation, clear paths for innovation, … Continued
SENSA includes an innovative locking feature and battery take back program WINSTON-SALEM, N.C. (July 1, 2024) – R.J. Reynolds Vapor Company (RJRVC), an operating company of Reynolds American Inc. (Reynolds American), the BAT Group’s U.S. subsidiary, today announced that it is expanding its innovative vapor portfolio with SENSA, a zero nicotine vapor product. SENSA … Continued
Vuse Pro device uses technology to unlock after verifying adult consumers are at least 21 years old and above the legal minimum purchase age to purchase tobacco and vapor products Vuse Pro device works with Vuse Pro pods Reynolds has provided the FDA with nearly 80,000 pages of scientific data for review as part of … Continued
At Reynolds, we are focused on paving the way to becoming a predominantly smokeless business by 2035. In its recent issue, Hispanic Executive showcases four of Reynolds’ accomplished Hispanic leaders—Luis Pinto, Patricia Mendoza Rodriguez, Valerie Mras, and Ricardo Guardo. Each leader has stepped up to help Reynolds reach its ambitious goals. While their respective roles, … Continued
Tobacco Harm Reduction is not only core to our company’s strategy, but it is an important initiative to create better public health outcomes for Americans. By focusing on Tobacco Harm Reduction, we are able to migrate adult cigarette smokers who do not wish to quit to potentially less harmful alternatives. We know that sustained and … Continued
Reynolds’ partnership with the National Association of Convenience Stores (“NACS”) and Conexxus bolsters national effort to make the process of verifying an adult tobacco consumer’s age more reliable and secure. Winston-Salem, N.C. (Feb. 2, 2022) – Reynolds American Inc. (Reynolds) today announced its partnership with the National Association of Convenience Stores (NACS) and Conexxus as a … Continued
Grouped Alto applications are final FDA submission for deemed products, representing both Vuse and VELO portfolios Reynolds completes 2020 deemed product PMTA submissions for one of the broadest portfolios in the industry Reynolds has provided the FDA with more than 530,000 pages of scientific data for review as part of all PMTA applications submitted More … Continued
VELO pouch is second group of PMTAs for VELO products, and completes current VELO brand PMTA submissions WINSTON-SALEM, NC. September 1, 2020 – Reynolds American Inc. (“Reynolds”) announces today the submission of a group of Premarket Tobacco Product Applications (“PMTAs”) to the U.S. Food and Drug Administration (“FDA”) seeking orders authorizing the marketing of VELO pouches. … Continued
FDA applications are a first for VELO’s dissolvable nicotine lozenges WINSTON-SALEM, N.C. – August 24, 2020 – Reynolds American Inc. (“Reynolds”) announces today the submission of a group of Premarket Tobacco Product Applications (“PMTAs”) to the U.S. Food and Drug Administration (“FDA”) seeking orders authorizing the marketing of VELO dissolvable nicotine lozenges. A grant of these … Continued
Vuse Vibe and Vuse Ciro join Reynolds’ Prior Vuse Solo Submission to FDA WINSTON-SALEM, N.C. – April 15, 2020 – Reynolds American (“Reynolds”) announced today that it has submitted two new Premarket Tobacco Product Applications (“PMTAs”) to the U.S. Food and Drug Administration (“FDA”). Reynolds is seeking marketing orders for their Vuse Vibe and Vuse Ciro … Continued